IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 371 10.54660/IJMBHR.2025.6.3.111-116 Study of Blood Transfusion Practices in Obstetric Patients at a Tertiary Care Centre PandeyNeha BansalAlpana GoelGunjan Postgraduate Resident Obstetrics and Gynecology, Department of Obstetrics and Gynaecology, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India Professor, Department of Obstetrics and Gynecology, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India Professor and HOD, Department of Obstetrics and Gynecology, Saraswathi Institute of Medical Sciences, Pilkhuwa, Hapur, Uttar Pradesh, India 21072025 6 3 111 116 05062025 07072025 CC BY-NC-SA 4.0

Blood transfusion in obstetric patients presents unique challenges due to physiological changes during pregnancy and the potential for massive hemorrhage, making understanding of transfusion practices and outcomes crucial for optimizing maternal care and reducing transfusion-related complications. This retrospective observational study aimed to analyze blood transfusion practices, indications, outcomes, and associated factors in obstetric patients at a tertiary care centre over a two-year period from January 2022 to December 2023. All obstetric patients who received blood transfusions during pregnancy, delivery, or postpartum period were included, with data collected on patient demographics, obstetric history, indications for transfusion, blood products used, pre and post-transfusion hemoglobin levels, complications, and maternal outcomes. Of 8,456 deliveries during the study period, 347 patients (4.1%) received blood transfusions with a mean age of 28.4 ± 5.2 years. Primary indications included postpartum hemorrhage (52.4%), antepartum hemorrhage (23.1%), and severe anemia (18.6%). Packed red blood cells were the most commonly transfused product (89.3%), followed by fresh frozen plasma (34.6%), with an average of 2.8 ± 1.6 units transfused per patient. Maternal mortality was 0.6% (2 cases), both associated with massive transfusion protocols, while post-transfusion hemoglobin levels showed significant improvement (p < 0.001). The study concluded that blood transfusion rates in obstetric patients remain significant, with postpartum hemorrhage being the leading indication, and standardized protocols and early intervention strategies can improve outcomes and reduce transfusion requirements.

 Blood TransfusionObstetric HemorrhagePostpartum HemorrhageMaternal MortalityAnemiaTertiary Care References Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015;28(3):275-284. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-333. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009;9:55. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113(8):919-924. Milman N. Anemia--still a major health problem in many parts of the world! Ann Hematol. 2011;90(4):369-377. Shander A, Knight K, Thurer R, et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116 Suppl 7A:58S-69S. Goodnough LT, Murphy MF. Do liberal blood transfusion policies increase patient exposure to the potential complications of homologous blood? J Trauma. 2009;66(3 Suppl):S68-71. Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol. 2013;122(1):120-126. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008;115(10):1265-1272. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol. 2010;202(4):353.e1-6. Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27-36. Pacheco LD, Saade GR, Costantine MM, et al. An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 2016;214(3):340-344. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011;83(6):719-724. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066-1074. Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet Gynecol. 2013;122(1):120-126. Green L, Knight M, Seeney FM, et al. The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study. BJOG. 2016;123(13):2164-2170. Ahmadzia HK, Phillips JM, Katler QS, et al. Transfusion-free treatment of postpartum hemorrhage: a systematic review. Am J Perinatol. 2018;35(5):424-431. Andrikopoulou M, D'Alton ME. Postpartum hemorrhage: early identification challenges. Semin Perinatol. 2019;43(1):11-17.